nodes	percent_of_prediction	percent_of_DWPC	metapath
Nalbuphine—Morphine—UGT2B15—prostate cancer	0.00583	0.236	CrCbGaD
Nalbuphine—Naloxone—TLR4—prostate cancer	0.00454	0.184	CrCbGaD
Nalbuphine—Buprenorphine—CYP2C18—prostate cancer	0.0023	0.0929	CrCbGaD
Nalbuphine—Oxycodone—CYP3A5—prostate cancer	0.00164	0.0664	CrCbGaD
Nalbuphine—Buprenorphine—CYP3A5—prostate cancer	0.00151	0.0612	CrCbGaD
Nalbuphine—Buprenorphine—CYP2A6—prostate cancer	0.00146	0.0593	CrCbGaD
Nalbuphine—Naloxone—ESR1—prostate cancer	0.00127	0.0515	CrCbGaD
Nalbuphine—Buprenorphine—CYP2C19—prostate cancer	0.00103	0.0417	CrCbGaD
Nalbuphine—Dihydrocodeine—CYP3A4—prostate cancer	0.00102	0.0411	CrCbGaD
Nalbuphine—Oxymorphone—CYP3A4—prostate cancer	0.000891	0.0361	CrCbGaD
Nalbuphine—Paraesthesia—Mitoxantrone—prostate cancer	0.000765	0.000958	CcSEcCtD
Nalbuphine—Loss of consciousness—Etoposide—prostate cancer	0.000764	0.000956	CcSEcCtD
Nalbuphine—Dizziness—Goserelin—prostate cancer	0.000763	0.000955	CcSEcCtD
Nalbuphine—Dyspnoea—Mitoxantrone—prostate cancer	0.00076	0.000952	CcSEcCtD
Nalbuphine—Somnolence—Mitoxantrone—prostate cancer	0.000758	0.000949	CcSEcCtD
Nalbuphine—Dizziness—Conjugated Estrogens—prostate cancer	0.000756	0.000946	CcSEcCtD
Nalbuphine—Feeling abnormal—Estradiol—prostate cancer	0.000754	0.000944	CcSEcCtD
Nalbuphine—Convulsion—Etoposide—prostate cancer	0.000753	0.000942	CcSEcCtD
Nalbuphine—Dyspepsia—Mitoxantrone—prostate cancer	0.00075	0.000939	CcSEcCtD
Nalbuphine—Hypertension—Etoposide—prostate cancer	0.00075	0.000939	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Estradiol—prostate cancer	0.000748	0.000937	CcSEcCtD
Nalbuphine—Flushing—Capecitabine—prostate cancer	0.000745	0.000933	CcSEcCtD
Nalbuphine—Vomiting—Goserelin—prostate cancer	0.000734	0.000919	CcSEcCtD
Nalbuphine—Bradycardia—Prednisone—prostate cancer	0.000728	0.000912	CcSEcCtD
Nalbuphine—Rash—Goserelin—prostate cancer	0.000728	0.000911	CcSEcCtD
Nalbuphine—Dermatitis—Goserelin—prostate cancer	0.000727	0.00091	CcSEcCtD
Nalbuphine—Vomiting—Conjugated Estrogens—prostate cancer	0.000727	0.00091	CcSEcCtD
Nalbuphine—Urticaria—Estradiol—prostate cancer	0.000727	0.00091	CcSEcCtD
Nalbuphine—Abdominal pain—Estradiol—prostate cancer	0.000723	0.000906	CcSEcCtD
Nalbuphine—Body temperature increased—Estradiol—prostate cancer	0.000723	0.000906	CcSEcCtD
Nalbuphine—Headache—Goserelin—prostate cancer	0.000723	0.000905	CcSEcCtD
Nalbuphine—Erythema—Docetaxel—prostate cancer	0.000722	0.000904	CcSEcCtD
Nalbuphine—Rash—Conjugated Estrogens—prostate cancer	0.000721	0.000902	CcSEcCtD
Nalbuphine—Dermatitis—Conjugated Estrogens—prostate cancer	0.00072	0.000902	CcSEcCtD
Nalbuphine—Headache—Conjugated Estrogens—prostate cancer	0.000716	0.000897	CcSEcCtD
Nalbuphine—Confusional state—Etoposide—prostate cancer	0.000715	0.000895	CcSEcCtD
Nalbuphine—Hallucination—Prednisone—prostate cancer	0.000712	0.000891	CcSEcCtD
Nalbuphine—Cardiac arrest—Doxorubicin—prostate cancer	0.000711	0.000891	CcSEcCtD
Nalbuphine—Oxycodone—CYP3A4—prostate cancer	0.000711	0.0288	CrCbGaD
Nalbuphine—Dysgeusia—Docetaxel—prostate cancer	0.000707	0.000885	CcSEcCtD
Nalbuphine—Feeling abnormal—Mitoxantrone—prostate cancer	0.000702	0.00088	CcSEcCtD
Nalbuphine—Erythema—Capecitabine—prostate cancer	0.000699	0.000875	CcSEcCtD
Nalbuphine—Asthma—Epirubicin—prostate cancer	0.000699	0.000875	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Mitoxantrone—prostate cancer	0.000697	0.000873	CcSEcCtD
Nalbuphine—Muscle spasms—Docetaxel—prostate cancer	0.000694	0.000869	CcSEcCtD
Nalbuphine—Tachycardia—Etoposide—prostate cancer	0.000692	0.000866	CcSEcCtD
Nalbuphine—Nausea—Goserelin—prostate cancer	0.000685	0.000858	CcSEcCtD
Nalbuphine—Hyperhidrosis—Etoposide—prostate cancer	0.000685	0.000858	CcSEcCtD
Nalbuphine—Dysgeusia—Capecitabine—prostate cancer	0.000684	0.000857	CcSEcCtD
Nalbuphine—Nausea—Conjugated Estrogens—prostate cancer	0.000679	0.00085	CcSEcCtD
Nalbuphine—Urticaria—Mitoxantrone—prostate cancer	0.000677	0.000848	CcSEcCtD
Nalbuphine—Hypersensitivity—Estradiol—prostate cancer	0.000674	0.000844	CcSEcCtD
Nalbuphine—Body temperature increased—Mitoxantrone—prostate cancer	0.000674	0.000844	CcSEcCtD
Nalbuphine—Abdominal pain—Mitoxantrone—prostate cancer	0.000674	0.000844	CcSEcCtD
Nalbuphine—Muscle spasms—Capecitabine—prostate cancer	0.000672	0.000841	CcSEcCtD
Nalbuphine—Flushing—Prednisone—prostate cancer	0.000664	0.000831	CcSEcCtD
Nalbuphine—Hypotension—Etoposide—prostate cancer	0.000662	0.00083	CcSEcCtD
Nalbuphine—Vision blurred—Capecitabine—prostate cancer	0.000659	0.000825	CcSEcCtD
Nalbuphine—Asthenia—Estradiol—prostate cancer	0.000656	0.000822	CcSEcCtD
Nalbuphine—Tremor—Capecitabine—prostate cancer	0.000655	0.00082	CcSEcCtD
Nalbuphine—Buprenorphine—CYP3A4—prostate cancer	0.000655	0.0265	CrCbGaD
Nalbuphine—Naloxone—CYP3A4—prostate cancer	0.00065	0.0263	CrCbGaD
Nalbuphine—Syncope—Docetaxel—prostate cancer	0.000647	0.000811	CcSEcCtD
Nalbuphine—Pruritus—Estradiol—prostate cancer	0.000647	0.00081	CcSEcCtD
Nalbuphine—Asthma—Doxorubicin—prostate cancer	0.000647	0.00081	CcSEcCtD
Nalbuphine—Pollakiuria—Epirubicin—prostate cancer	0.000646	0.000808	CcSEcCtD
Nalbuphine—Hydromorphone—CYP3A4—prostate cancer	0.000645	0.0261	CrCbGaD
Nalbuphine—Paraesthesia—Etoposide—prostate cancer	0.000637	0.000797	CcSEcCtD
Nalbuphine—Loss of consciousness—Docetaxel—prostate cancer	0.000635	0.000795	CcSEcCtD
Nalbuphine—Dyspnoea—Etoposide—prostate cancer	0.000632	0.000791	CcSEcCtD
Nalbuphine—Somnolence—Etoposide—prostate cancer	0.00063	0.000789	CcSEcCtD
Nalbuphine—Vertigo—Capecitabine—prostate cancer	0.000628	0.000786	CcSEcCtD
Nalbuphine—Hypersensitivity—Mitoxantrone—prostate cancer	0.000628	0.000786	CcSEcCtD
Nalbuphine—Syncope—Capecitabine—prostate cancer	0.000627	0.000785	CcSEcCtD
Nalbuphine—Convulsion—Docetaxel—prostate cancer	0.000626	0.000783	CcSEcCtD
Nalbuphine—Hypertension—Docetaxel—prostate cancer	0.000623	0.00078	CcSEcCtD
Nalbuphine—Erythema—Prednisone—prostate cancer	0.000623	0.00078	CcSEcCtD
Nalbuphine—Loss of consciousness—Capecitabine—prostate cancer	0.000614	0.000769	CcSEcCtD
Nalbuphine—Asthenia—Mitoxantrone—prostate cancer	0.000612	0.000766	CcSEcCtD
Nalbuphine—Dizziness—Estradiol—prostate cancer	0.000605	0.000757	CcSEcCtD
Nalbuphine—Hypertension—Capecitabine—prostate cancer	0.000603	0.000756	CcSEcCtD
Nalbuphine—Dry mouth—Docetaxel—prostate cancer	0.000601	0.000753	CcSEcCtD
Nalbuphine—Pollakiuria—Doxorubicin—prostate cancer	0.000597	0.000748	CcSEcCtD
Nalbuphine—Confusional state—Docetaxel—prostate cancer	0.000594	0.000744	CcSEcCtD
Nalbuphine—Anxiety—Capecitabine—prostate cancer	0.000593	0.000743	CcSEcCtD
Nalbuphine—Oedema—Docetaxel—prostate cancer	0.000589	0.000738	CcSEcCtD
Nalbuphine—Vision blurred—Prednisone—prostate cancer	0.000587	0.000735	CcSEcCtD
Nalbuphine—Feeling abnormal—Etoposide—prostate cancer	0.000584	0.000732	CcSEcCtD
Nalbuphine—Dry mouth—Capecitabine—prostate cancer	0.000582	0.000729	CcSEcCtD
Nalbuphine—Vomiting—Estradiol—prostate cancer	0.000582	0.000728	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Etoposide—prostate cancer	0.00058	0.000726	CcSEcCtD
Nalbuphine—Shock—Docetaxel—prostate cancer	0.00058	0.000726	CcSEcCtD
Nalbuphine—Rash—Estradiol—prostate cancer	0.000577	0.000722	CcSEcCtD
Nalbuphine—Dermatitis—Estradiol—prostate cancer	0.000576	0.000722	CcSEcCtD
Nalbuphine—Confusional state—Capecitabine—prostate cancer	0.000575	0.00072	CcSEcCtD
Nalbuphine—Tachycardia—Docetaxel—prostate cancer	0.000575	0.00072	CcSEcCtD
Nalbuphine—Headache—Estradiol—prostate cancer	0.000573	0.000718	CcSEcCtD
Nalbuphine—Agitation—Prednisone—prostate cancer	0.000572	0.000716	CcSEcCtD
Nalbuphine—Oedema—Capecitabine—prostate cancer	0.00057	0.000714	CcSEcCtD
Nalbuphine—Bradycardia—Epirubicin—prostate cancer	0.000569	0.000713	CcSEcCtD
Nalbuphine—Urticaria—Etoposide—prostate cancer	0.000563	0.000705	CcSEcCtD
Nalbuphine—Shock—Capecitabine—prostate cancer	0.000561	0.000703	CcSEcCtD
Nalbuphine—Abdominal pain—Etoposide—prostate cancer	0.00056	0.000702	CcSEcCtD
Nalbuphine—Body temperature increased—Etoposide—prostate cancer	0.00056	0.000702	CcSEcCtD
Nalbuphine—Vertigo—Prednisone—prostate cancer	0.000559	0.0007	CcSEcCtD
Nalbuphine—Syncope—Prednisone—prostate cancer	0.000558	0.000699	CcSEcCtD
Nalbuphine—Tachycardia—Capecitabine—prostate cancer	0.000557	0.000697	CcSEcCtD
Nalbuphine—Hypoaesthesia—Epirubicin—prostate cancer	0.000557	0.000697	CcSEcCtD
Nalbuphine—Hyperhidrosis—Capecitabine—prostate cancer	0.000551	0.000691	CcSEcCtD
Nalbuphine—Hypotension—Docetaxel—prostate cancer	0.000551	0.000689	CcSEcCtD
Nalbuphine—Morphine—CYP3A4—prostate cancer	0.000549	0.0222	CrCbGaD
Nalbuphine—Loss of consciousness—Prednisone—prostate cancer	0.000547	0.000685	CcSEcCtD
Nalbuphine—Nausea—Estradiol—prostate cancer	0.000543	0.00068	CcSEcCtD
Nalbuphine—Vomiting—Mitoxantrone—prostate cancer	0.000542	0.000679	CcSEcCtD
Nalbuphine—Convulsion—Prednisone—prostate cancer	0.000539	0.000675	CcSEcCtD
Nalbuphine—Hypertension—Prednisone—prostate cancer	0.000538	0.000673	CcSEcCtD
Nalbuphine—Rash—Mitoxantrone—prostate cancer	0.000537	0.000673	CcSEcCtD
Nalbuphine—Dermatitis—Mitoxantrone—prostate cancer	0.000537	0.000672	CcSEcCtD
Nalbuphine—Headache—Mitoxantrone—prostate cancer	0.000534	0.000669	CcSEcCtD
Nalbuphine—Hypotension—Capecitabine—prostate cancer	0.000533	0.000667	CcSEcCtD
Nalbuphine—Paraesthesia—Docetaxel—prostate cancer	0.000529	0.000662	CcSEcCtD
Nalbuphine—Anxiety—Prednisone—prostate cancer	0.000528	0.000661	CcSEcCtD
Nalbuphine—Bradycardia—Doxorubicin—prostate cancer	0.000527	0.00066	CcSEcCtD
Nalbuphine—Dyspnoea—Docetaxel—prostate cancer	0.000525	0.000658	CcSEcCtD
Nalbuphine—Somnolence—Docetaxel—prostate cancer	0.000524	0.000656	CcSEcCtD
Nalbuphine—Hypersensitivity—Etoposide—prostate cancer	0.000522	0.000654	CcSEcCtD
Nalbuphine—Flushing—Epirubicin—prostate cancer	0.000519	0.00065	CcSEcCtD
Nalbuphine—Dyspepsia—Docetaxel—prostate cancer	0.000519	0.000649	CcSEcCtD
Nalbuphine—Hypoaesthesia—Doxorubicin—prostate cancer	0.000515	0.000645	CcSEcCtD
Nalbuphine—Paraesthesia—Capecitabine—prostate cancer	0.000512	0.000641	CcSEcCtD
Nalbuphine—Asthenia—Etoposide—prostate cancer	0.000509	0.000637	CcSEcCtD
Nalbuphine—Dyspnoea—Capecitabine—prostate cancer	0.000509	0.000637	CcSEcCtD
Nalbuphine—Oedema—Prednisone—prostate cancer	0.000508	0.000636	CcSEcCtD
Nalbuphine—Nausea—Mitoxantrone—prostate cancer	0.000506	0.000634	CcSEcCtD
Nalbuphine—Dyspepsia—Capecitabine—prostate cancer	0.000502	0.000629	CcSEcCtD
Nalbuphine—Pruritus—Etoposide—prostate cancer	0.000502	0.000628	CcSEcCtD
Nalbuphine—Shock—Prednisone—prostate cancer	0.0005	0.000626	CcSEcCtD
Nalbuphine—Tachycardia—Prednisone—prostate cancer	0.000496	0.000621	CcSEcCtD
Nalbuphine—Hyperhidrosis—Prednisone—prostate cancer	0.000491	0.000615	CcSEcCtD
Nalbuphine—Erythema—Epirubicin—prostate cancer	0.000487	0.00061	CcSEcCtD
Nalbuphine—Feeling abnormal—Docetaxel—prostate cancer	0.000486	0.000608	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Docetaxel—prostate cancer	0.000482	0.000603	CcSEcCtD
Nalbuphine—Flushing—Doxorubicin—prostate cancer	0.00048	0.000601	CcSEcCtD
Nalbuphine—Tension—Epirubicin—prostate cancer	0.000478	0.000598	CcSEcCtD
Nalbuphine—Dysgeusia—Epirubicin—prostate cancer	0.000477	0.000597	CcSEcCtD
Nalbuphine—Nervousness—Epirubicin—prostate cancer	0.000473	0.000592	CcSEcCtD
Nalbuphine—Feeling abnormal—Capecitabine—prostate cancer	0.00047	0.000589	CcSEcCtD
Nalbuphine—Dizziness—Etoposide—prostate cancer	0.000469	0.000587	CcSEcCtD
Nalbuphine—Muscle spasms—Epirubicin—prostate cancer	0.000468	0.000586	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Capecitabine—prostate cancer	0.000466	0.000584	CcSEcCtD
Nalbuphine—Abdominal pain—Docetaxel—prostate cancer	0.000466	0.000583	CcSEcCtD
Nalbuphine—Body temperature increased—Docetaxel—prostate cancer	0.000466	0.000583	CcSEcCtD
Nalbuphine—Vision blurred—Epirubicin—prostate cancer	0.000459	0.000575	CcSEcCtD
Nalbuphine—Paraesthesia—Prednisone—prostate cancer	0.000456	0.000571	CcSEcCtD
Nalbuphine—Urticaria—Capecitabine—prostate cancer	0.000453	0.000567	CcSEcCtD
Nalbuphine—Body temperature increased—Capecitabine—prostate cancer	0.000451	0.000565	CcSEcCtD
Nalbuphine—Abdominal pain—Capecitabine—prostate cancer	0.000451	0.000565	CcSEcCtD
Nalbuphine—Vomiting—Etoposide—prostate cancer	0.000451	0.000564	CcSEcCtD
Nalbuphine—Erythema—Doxorubicin—prostate cancer	0.000451	0.000564	CcSEcCtD
Nalbuphine—Agitation—Epirubicin—prostate cancer	0.000447	0.00056	CcSEcCtD
Nalbuphine—Dyspepsia—Prednisone—prostate cancer	0.000447	0.00056	CcSEcCtD
Nalbuphine—Rash—Etoposide—prostate cancer	0.000447	0.00056	CcSEcCtD
Nalbuphine—Dermatitis—Etoposide—prostate cancer	0.000447	0.000559	CcSEcCtD
Nalbuphine—Headache—Etoposide—prostate cancer	0.000444	0.000556	CcSEcCtD
Nalbuphine—Tension—Doxorubicin—prostate cancer	0.000442	0.000554	CcSEcCtD
Nalbuphine—Dysgeusia—Doxorubicin—prostate cancer	0.000441	0.000552	CcSEcCtD
Nalbuphine—Nervousness—Doxorubicin—prostate cancer	0.000438	0.000548	CcSEcCtD
Nalbuphine—Vertigo—Epirubicin—prostate cancer	0.000437	0.000548	CcSEcCtD
Nalbuphine—Syncope—Epirubicin—prostate cancer	0.000437	0.000547	CcSEcCtD
Nalbuphine—Hypersensitivity—Docetaxel—prostate cancer	0.000434	0.000544	CcSEcCtD
Nalbuphine—Muscle spasms—Doxorubicin—prostate cancer	0.000433	0.000542	CcSEcCtD
Nalbuphine—Loss of consciousness—Epirubicin—prostate cancer	0.000428	0.000536	CcSEcCtD
Nalbuphine—Vision blurred—Doxorubicin—prostate cancer	0.000425	0.000532	CcSEcCtD
Nalbuphine—Asthenia—Docetaxel—prostate cancer	0.000423	0.000529	CcSEcCtD
Nalbuphine—Convulsion—Epirubicin—prostate cancer	0.000422	0.000528	CcSEcCtD
Nalbuphine—Nausea—Etoposide—prostate cancer	0.000421	0.000527	CcSEcCtD
Nalbuphine—Hypertension—Epirubicin—prostate cancer	0.00042	0.000526	CcSEcCtD
Nalbuphine—Hypersensitivity—Capecitabine—prostate cancer	0.00042	0.000526	CcSEcCtD
Nalbuphine—Feeling abnormal—Prednisone—prostate cancer	0.000419	0.000524	CcSEcCtD
Nalbuphine—Pruritus—Docetaxel—prostate cancer	0.000417	0.000522	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Prednisone—prostate cancer	0.000416	0.00052	CcSEcCtD
Nalbuphine—Agitation—Doxorubicin—prostate cancer	0.000414	0.000518	CcSEcCtD
Nalbuphine—Anxiety—Epirubicin—prostate cancer	0.000413	0.000517	CcSEcCtD
Nalbuphine—Asthenia—Capecitabine—prostate cancer	0.000409	0.000513	CcSEcCtD
Nalbuphine—Dry mouth—Epirubicin—prostate cancer	0.000405	0.000508	CcSEcCtD
Nalbuphine—Vertigo—Doxorubicin—prostate cancer	0.000405	0.000507	CcSEcCtD
Nalbuphine—Syncope—Doxorubicin—prostate cancer	0.000404	0.000506	CcSEcCtD
Nalbuphine—Urticaria—Prednisone—prostate cancer	0.000404	0.000505	CcSEcCtD
Nalbuphine—Pruritus—Capecitabine—prostate cancer	0.000404	0.000505	CcSEcCtD
Nalbuphine—Body temperature increased—Prednisone—prostate cancer	0.000402	0.000503	CcSEcCtD
Nalbuphine—Abdominal pain—Prednisone—prostate cancer	0.000402	0.000503	CcSEcCtD
Nalbuphine—Confusional state—Epirubicin—prostate cancer	0.000401	0.000502	CcSEcCtD
Nalbuphine—Oedema—Epirubicin—prostate cancer	0.000397	0.000498	CcSEcCtD
Nalbuphine—Loss of consciousness—Doxorubicin—prostate cancer	0.000396	0.000496	CcSEcCtD
Nalbuphine—Shock—Epirubicin—prostate cancer	0.000391	0.00049	CcSEcCtD
Nalbuphine—Convulsion—Doxorubicin—prostate cancer	0.00039	0.000489	CcSEcCtD
Nalbuphine—Dizziness—Docetaxel—prostate cancer	0.00039	0.000488	CcSEcCtD
Nalbuphine—Hypertension—Doxorubicin—prostate cancer	0.000389	0.000487	CcSEcCtD
Nalbuphine—Tachycardia—Epirubicin—prostate cancer	0.000388	0.000486	CcSEcCtD
Nalbuphine—Hyperhidrosis—Epirubicin—prostate cancer	0.000384	0.000481	CcSEcCtD
Nalbuphine—Anxiety—Doxorubicin—prostate cancer	0.000382	0.000479	CcSEcCtD
Nalbuphine—Dizziness—Capecitabine—prostate cancer	0.000377	0.000472	CcSEcCtD
Nalbuphine—Dry mouth—Doxorubicin—prostate cancer	0.000375	0.00047	CcSEcCtD
Nalbuphine—Vomiting—Docetaxel—prostate cancer	0.000375	0.000469	CcSEcCtD
Nalbuphine—Hypersensitivity—Prednisone—prostate cancer	0.000374	0.000469	CcSEcCtD
Nalbuphine—Rash—Docetaxel—prostate cancer	0.000372	0.000465	CcSEcCtD
Nalbuphine—Hypotension—Epirubicin—prostate cancer	0.000371	0.000465	CcSEcCtD
Nalbuphine—Dermatitis—Docetaxel—prostate cancer	0.000371	0.000465	CcSEcCtD
Nalbuphine—Confusional state—Doxorubicin—prostate cancer	0.000371	0.000464	CcSEcCtD
Nalbuphine—Headache—Docetaxel—prostate cancer	0.000369	0.000462	CcSEcCtD
Nalbuphine—Oedema—Doxorubicin—prostate cancer	0.000368	0.00046	CcSEcCtD
Nalbuphine—Asthenia—Prednisone—prostate cancer	0.000365	0.000457	CcSEcCtD
Nalbuphine—Vomiting—Capecitabine—prostate cancer	0.000363	0.000454	CcSEcCtD
Nalbuphine—Shock—Doxorubicin—prostate cancer	0.000362	0.000453	CcSEcCtD
Nalbuphine—Rash—Capecitabine—prostate cancer	0.00036	0.00045	CcSEcCtD
Nalbuphine—Pruritus—Prednisone—prostate cancer	0.00036	0.00045	CcSEcCtD
Nalbuphine—Dermatitis—Capecitabine—prostate cancer	0.000359	0.00045	CcSEcCtD
Nalbuphine—Tachycardia—Doxorubicin—prostate cancer	0.000359	0.000449	CcSEcCtD
Nalbuphine—Headache—Capecitabine—prostate cancer	0.000357	0.000447	CcSEcCtD
Nalbuphine—Paraesthesia—Epirubicin—prostate cancer	0.000357	0.000447	CcSEcCtD
Nalbuphine—Hyperhidrosis—Doxorubicin—prostate cancer	0.000355	0.000445	CcSEcCtD
Nalbuphine—Dyspnoea—Epirubicin—prostate cancer	0.000354	0.000444	CcSEcCtD
Nalbuphine—Somnolence—Epirubicin—prostate cancer	0.000353	0.000442	CcSEcCtD
Nalbuphine—Nausea—Docetaxel—prostate cancer	0.00035	0.000438	CcSEcCtD
Nalbuphine—Dyspepsia—Epirubicin—prostate cancer	0.00035	0.000438	CcSEcCtD
Nalbuphine—Hypotension—Doxorubicin—prostate cancer	0.000344	0.00043	CcSEcCtD
Nalbuphine—Nausea—Capecitabine—prostate cancer	0.000339	0.000424	CcSEcCtD
Nalbuphine—Dizziness—Prednisone—prostate cancer	0.000336	0.000421	CcSEcCtD
Nalbuphine—Paraesthesia—Doxorubicin—prostate cancer	0.00033	0.000413	CcSEcCtD
Nalbuphine—Dyspnoea—Doxorubicin—prostate cancer	0.000328	0.000411	CcSEcCtD
Nalbuphine—Feeling abnormal—Epirubicin—prostate cancer	0.000327	0.00041	CcSEcCtD
Nalbuphine—Somnolence—Doxorubicin—prostate cancer	0.000327	0.000409	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Epirubicin—prostate cancer	0.000325	0.000407	CcSEcCtD
Nalbuphine—Dyspepsia—Doxorubicin—prostate cancer	0.000324	0.000405	CcSEcCtD
Nalbuphine—Vomiting—Prednisone—prostate cancer	0.000323	0.000405	CcSEcCtD
Nalbuphine—Rash—Prednisone—prostate cancer	0.00032	0.000401	CcSEcCtD
Nalbuphine—Dermatitis—Prednisone—prostate cancer	0.00032	0.000401	CcSEcCtD
Nalbuphine—Headache—Prednisone—prostate cancer	0.000318	0.000399	CcSEcCtD
Nalbuphine—Urticaria—Epirubicin—prostate cancer	0.000316	0.000395	CcSEcCtD
Nalbuphine—Abdominal pain—Epirubicin—prostate cancer	0.000314	0.000393	CcSEcCtD
Nalbuphine—Body temperature increased—Epirubicin—prostate cancer	0.000314	0.000393	CcSEcCtD
Nalbuphine—Feeling abnormal—Doxorubicin—prostate cancer	0.000303	0.000379	CcSEcCtD
Nalbuphine—Nausea—Prednisone—prostate cancer	0.000302	0.000378	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Doxorubicin—prostate cancer	0.000301	0.000377	CcSEcCtD
Nalbuphine—Hypersensitivity—Epirubicin—prostate cancer	0.000293	0.000367	CcSEcCtD
Nalbuphine—Urticaria—Doxorubicin—prostate cancer	0.000292	0.000366	CcSEcCtD
Nalbuphine—Abdominal pain—Doxorubicin—prostate cancer	0.000291	0.000364	CcSEcCtD
Nalbuphine—Body temperature increased—Doxorubicin—prostate cancer	0.000291	0.000364	CcSEcCtD
Nalbuphine—Asthenia—Epirubicin—prostate cancer	0.000285	0.000357	CcSEcCtD
Nalbuphine—Pruritus—Epirubicin—prostate cancer	0.000281	0.000352	CcSEcCtD
Nalbuphine—Hypersensitivity—Doxorubicin—prostate cancer	0.000271	0.000339	CcSEcCtD
Nalbuphine—Asthenia—Doxorubicin—prostate cancer	0.000264	0.00033	CcSEcCtD
Nalbuphine—Dizziness—Epirubicin—prostate cancer	0.000263	0.000329	CcSEcCtD
Nalbuphine—Pruritus—Doxorubicin—prostate cancer	0.00026	0.000326	CcSEcCtD
Nalbuphine—Vomiting—Epirubicin—prostate cancer	0.000253	0.000316	CcSEcCtD
Nalbuphine—Rash—Epirubicin—prostate cancer	0.000251	0.000314	CcSEcCtD
Nalbuphine—Dermatitis—Epirubicin—prostate cancer	0.00025	0.000313	CcSEcCtD
Nalbuphine—Headache—Epirubicin—prostate cancer	0.000249	0.000312	CcSEcCtD
Nalbuphine—Dizziness—Doxorubicin—prostate cancer	0.000243	0.000304	CcSEcCtD
Nalbuphine—Nausea—Epirubicin—prostate cancer	0.000236	0.000296	CcSEcCtD
Nalbuphine—Vomiting—Doxorubicin—prostate cancer	0.000234	0.000293	CcSEcCtD
Nalbuphine—Rash—Doxorubicin—prostate cancer	0.000232	0.00029	CcSEcCtD
Nalbuphine—Dermatitis—Doxorubicin—prostate cancer	0.000232	0.00029	CcSEcCtD
Nalbuphine—Headache—Doxorubicin—prostate cancer	0.00023	0.000288	CcSEcCtD
Nalbuphine—Nausea—Doxorubicin—prostate cancer	0.000218	0.000274	CcSEcCtD
Nalbuphine—OPRD1—Signaling Pathways—NGFR—prostate cancer	7.83e-05	0.000443	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—FGFR4—prostate cancer	7.8e-05	0.000442	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PARP1—prostate cancer	7.8e-05	0.000442	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—MAP3K7—prostate cancer	7.74e-05	0.000438	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CALCA—prostate cancer	7.71e-05	0.000436	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CXCL12—prostate cancer	7.53e-05	0.000426	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—FGF10—prostate cancer	7.44e-05	0.000421	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—TGFBR1—prostate cancer	7.4e-05	0.000419	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PTHLH—prostate cancer	7.4e-05	0.000419	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—ADRB2—prostate cancer	7.37e-05	0.000417	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—AKR1C3—prostate cancer	7.28e-05	0.000412	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—JAK2—prostate cancer	7.27e-05	0.000411	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PRKACB—prostate cancer	7.24e-05	0.00041	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—MAP2K1—prostate cancer	7.24e-05	0.00041	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—PIK3CD—prostate cancer	7.19e-05	0.000407	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—VAV3—prostate cancer	7.18e-05	0.000407	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—PIK3CG—prostate cancer	7.17e-05	0.000406	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CASP9—prostate cancer	7.09e-05	0.000401	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—TGFBR2—prostate cancer	7.08e-05	0.000401	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PPP3CA—prostate cancer	7.06e-05	0.0004	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—THBS1—prostate cancer	7.06e-05	0.0004	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—ITPR1—prostate cancer	6.97e-05	0.000394	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—ANXA1—prostate cancer	6.96e-05	0.000394	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—PIK3CD—prostate cancer	6.94e-05	0.000393	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—PIK3CB—prostate cancer	6.9e-05	0.000391	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PRKCQ—prostate cancer	6.87e-05	0.000389	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—NGFR—prostate cancer	6.87e-05	0.000389	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PRKCZ—prostate cancer	6.83e-05	0.000386	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—MAP3K7—prostate cancer	6.79e-05	0.000384	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—PIK3CG—prostate cancer	6.67e-05	0.000378	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—IGF1R—prostate cancer	6.66e-05	0.000377	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—CXCL8—prostate cancer	6.63e-05	0.000375	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—JAK2—prostate cancer	6.6e-05	0.000373	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—FGFR4—prostate cancer	6.6e-05	0.000373	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PARP1—prostate cancer	6.6e-05	0.000373	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—FGF10—prostate cancer	6.53e-05	0.000369	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CALCA—prostate cancer	6.51e-05	0.000369	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—ADRB2—prostate cancer	6.46e-05	0.000366	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—LPL—prostate cancer	6.39e-05	0.000361	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—JAK2—prostate cancer	6.37e-05	0.000361	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CXCL12—prostate cancer	6.36e-05	0.00036	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—MAP2K1—prostate cancer	6.35e-05	0.000359	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—IL2—prostate cancer	6.34e-05	0.000359	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PDGFRB—prostate cancer	6.33e-05	0.000358	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—PIK3CD—prostate cancer	6.3e-05	0.000357	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—VAV3—prostate cancer	6.3e-05	0.000356	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—PIK3CB—prostate cancer	6.27e-05	0.000355	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—TGFBR2—prostate cancer	6.21e-05	0.000351	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—ITGB3—prostate cancer	6.17e-05	0.000349	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—ITPR1—prostate cancer	6.11e-05	0.000346	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—PIK3CG—prostate cancer	6.06e-05	0.000343	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—PIK3CB—prostate cancer	6.05e-05	0.000342	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—CXCL8—prostate cancer	6.02e-05	0.000341	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CASP9—prostate cancer	5.99e-05	0.000339	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—ERBB3—prostate cancer	5.98e-05	0.000339	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—FGFR2—prostate cancer	5.97e-05	0.000338	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—PIK3CD—prostate cancer	5.87e-05	0.000332	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—IGF1R—prostate cancer	5.84e-05	0.000331	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—CXCL8—prostate cancer	5.82e-05	0.000329	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—NGFR—prostate cancer	5.81e-05	0.000329	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PRKCQ—prostate cancer	5.81e-05	0.000329	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—JAK2—prostate cancer	5.79e-05	0.000327	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—IL2—prostate cancer	5.76e-05	0.000326	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—MAP3K7—prostate cancer	5.74e-05	0.000325	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—TERT—prostate cancer	5.73e-05	0.000325	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—LPL—prostate cancer	5.6e-05	0.000317	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—IL2—prostate cancer	5.56e-05	0.000315	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PDGFRB—prostate cancer	5.55e-05	0.000314	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—FGF10—prostate cancer	5.52e-05	0.000312	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—PIK3CB—prostate cancer	5.5e-05	0.000311	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—HIF1A—prostate cancer	5.48e-05	0.00031	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—ADRB2—prostate cancer	5.46e-05	0.000309	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—ITGB3—prostate cancer	5.41e-05	0.000306	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—JAK2—prostate cancer	5.39e-05	0.000305	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—MAP2K1—prostate cancer	5.36e-05	0.000304	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—LEP—prostate cancer	5.35e-05	0.000303	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—PIK3CD—prostate cancer	5.33e-05	0.000302	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—VAV3—prostate cancer	5.32e-05	0.000301	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CAV1—prostate cancer	5.3e-05	0.0003	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—CXCL8—prostate cancer	5.28e-05	0.000299	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—TGFBR2—prostate cancer	5.25e-05	0.000297	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—ERBB3—prostate cancer	5.25e-05	0.000297	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—KDR—prostate cancer	5.24e-05	0.000297	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—FGFR2—prostate cancer	5.24e-05	0.000296	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—ITPR1—prostate cancer	5.16e-05	0.000292	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—PIK3CB—prostate cancer	5.11e-05	0.000289	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—ESR1—prostate cancer	5.11e-05	0.000289	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—IL2—prostate cancer	5.05e-05	0.000286	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—TERT—prostate cancer	5.03e-05	0.000285	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—BAD—prostate cancer	4.99e-05	0.000282	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—IGF1R—prostate cancer	4.94e-05	0.000279	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—CXCL8—prostate cancer	4.91e-05	0.000278	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—JAK2—prostate cancer	4.89e-05	0.000277	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PIK3CG—prostate cancer	4.83e-05	0.000273	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—APC—prostate cancer	4.83e-05	0.000273	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—HIF1A—prostate cancer	4.81e-05	0.000272	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—IRS1—prostate cancer	4.78e-05	0.00027	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—EGF—prostate cancer	4.78e-05	0.00027	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—LPL—prostate cancer	4.73e-05	0.000268	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—IL2—prostate cancer	4.7e-05	0.000266	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—LEP—prostate cancer	4.69e-05	0.000266	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PDGFRB—prostate cancer	4.69e-05	0.000265	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CAV1—prostate cancer	4.65e-05	0.000263	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—PIK3CB—prostate cancer	4.64e-05	0.000263	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—GSK3B—prostate cancer	4.64e-05	0.000262	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—KDR—prostate cancer	4.6e-05	0.00026	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—INS—prostate cancer	4.57e-05	0.000259	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—ITGB3—prostate cancer	4.57e-05	0.000259	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—ESR1—prostate cancer	4.48e-05	0.000254	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CREBBP—prostate cancer	4.48e-05	0.000254	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—CXCL8—prostate cancer	4.46e-05	0.000253	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—ERBB3—prostate cancer	4.43e-05	0.000251	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—FGFR2—prostate cancer	4.43e-05	0.000251	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—IGF1—prostate cancer	4.42e-05	0.00025	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—EGFR—prostate cancer	4.4e-05	0.000249	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—BAD—prostate cancer	4.37e-05	0.000248	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—MAP2K1—prostate cancer	4.28e-05	0.000242	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—IL2—prostate cancer	4.27e-05	0.000241	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—TERT—prostate cancer	4.25e-05	0.000241	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PIK3CD—prostate cancer	4.25e-05	0.00024	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—APC—prostate cancer	4.24e-05	0.00024	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PIK3CG—prostate cancer	4.24e-05	0.00024	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—PIK3CA—prostate cancer	4.21e-05	0.000238	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—SERPINE1—prostate cancer	4.2e-05	0.000238	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—IRS1—prostate cancer	4.19e-05	0.000237	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—EGF—prostate cancer	4.19e-05	0.000237	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—KRAS—prostate cancer	4.16e-05	0.000235	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—FGF2—prostate cancer	4.07e-05	0.00023	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—GSK3B—prostate cancer	4.07e-05	0.00023	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—HIF1A—prostate cancer	4.06e-05	0.00023	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—NOS3—prostate cancer	4.01e-05	0.000227	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—INS—prostate cancer	4.01e-05	0.000227	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—LEP—prostate cancer	3.97e-05	0.000225	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CAV1—prostate cancer	3.93e-05	0.000222	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CREBBP—prostate cancer	3.93e-05	0.000222	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—JAK2—prostate cancer	3.9e-05	0.000221	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—KDR—prostate cancer	3.89e-05	0.00022	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—IGF1—prostate cancer	3.88e-05	0.00022	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—EGFR—prostate cancer	3.86e-05	0.000218	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—PIK3CA—prostate cancer	3.82e-05	0.000216	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—MDM2—prostate cancer	3.81e-05	0.000215	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—ESR1—prostate cancer	3.79e-05	0.000214	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—ERBB2—prostate cancer	3.75e-05	0.000212	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—MAP2K1—prostate cancer	3.75e-05	0.000212	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PIK3CD—prostate cancer	3.72e-05	0.000211	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PIK3CB—prostate cancer	3.7e-05	0.00021	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—BAD—prostate cancer	3.7e-05	0.000209	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—PIK3CA—prostate cancer	3.69e-05	0.000209	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—SERPINE1—prostate cancer	3.68e-05	0.000208	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—KRAS—prostate cancer	3.65e-05	0.000206	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—APC—prostate cancer	3.58e-05	0.000203	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PIK3CG—prostate cancer	3.58e-05	0.000203	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—FGF2—prostate cancer	3.57e-05	0.000202	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CXCL8—prostate cancer	3.56e-05	0.000201	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—IRS1—prostate cancer	3.54e-05	0.0002	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—EGF—prostate cancer	3.54e-05	0.0002	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—NOS3—prostate cancer	3.52e-05	0.000199	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CDKN1B—prostate cancer	3.47e-05	0.000197	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—AKT1—prostate cancer	3.44e-05	0.000195	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—GSK3B—prostate cancer	3.44e-05	0.000194	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—JAK2—prostate cancer	3.42e-05	0.000193	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CASP3—prostate cancer	3.41e-05	0.000193	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—IL2—prostate cancer	3.4e-05	0.000192	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—INS—prostate cancer	3.39e-05	0.000192	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—IL6—prostate cancer	3.38e-05	0.000191	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—PIK3CA—prostate cancer	3.35e-05	0.00019	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—MDM2—prostate cancer	3.34e-05	0.000189	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CREBBP—prostate cancer	3.32e-05	0.000188	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CCND1—prostate cancer	3.31e-05	0.000188	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—ERBB2—prostate cancer	3.29e-05	0.000186	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CTNNB1—prostate cancer	3.28e-05	0.000186	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—IGF1—prostate cancer	3.28e-05	0.000186	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—EGFR—prostate cancer	3.26e-05	0.000185	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PIK3CB—prostate cancer	3.25e-05	0.000184	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—MMP9—prostate cancer	3.22e-05	0.000182	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CDKN1A—prostate cancer	3.21e-05	0.000181	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PTEN—prostate cancer	3.2e-05	0.000181	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—MAP2K1—prostate cancer	3.17e-05	0.000179	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PIK3CD—prostate cancer	3.15e-05	0.000178	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—AKT1—prostate cancer	3.12e-05	0.000177	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CXCL8—prostate cancer	3.12e-05	0.000177	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—PIK3CA—prostate cancer	3.12e-05	0.000176	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—SERPINE1—prostate cancer	3.11e-05	0.000176	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—KRAS—prostate cancer	3.08e-05	0.000174	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—EP300—prostate cancer	3.05e-05	0.000173	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CDKN1B—prostate cancer	3.05e-05	0.000172	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—FGF2—prostate cancer	3.01e-05	0.000171	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—AKT1—prostate cancer	3.01e-05	0.000171	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CASP3—prostate cancer	2.99e-05	0.000169	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—IL2—prostate cancer	2.98e-05	0.000169	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—NOS3—prostate cancer	2.97e-05	0.000168	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—SRC—prostate cancer	2.97e-05	0.000168	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—IL6—prostate cancer	2.97e-05	0.000168	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CCND1—prostate cancer	2.91e-05	0.000164	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—VEGFA—prostate cancer	2.89e-05	0.000164	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—JAK2—prostate cancer	2.89e-05	0.000163	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CTNNB1—prostate cancer	2.88e-05	0.000163	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—STAT3—prostate cancer	2.86e-05	0.000162	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—PIK3CA—prostate cancer	2.83e-05	0.00016	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—MMP9—prostate cancer	2.82e-05	0.00016	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—MDM2—prostate cancer	2.82e-05	0.00016	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CDKN1A—prostate cancer	2.81e-05	0.000159	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PTEN—prostate cancer	2.81e-05	0.000159	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—ERBB2—prostate cancer	2.78e-05	0.000157	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PIK3CB—prostate cancer	2.74e-05	0.000155	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—AKT1—prostate cancer	2.74e-05	0.000155	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—EP300—prostate cancer	2.68e-05	0.000151	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—MYC—prostate cancer	2.66e-05	0.00015	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—TGFB1—prostate cancer	2.65e-05	0.00015	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CXCL8—prostate cancer	2.64e-05	0.000149	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—SRC—prostate cancer	2.6e-05	0.000147	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—EGFR—prostate cancer	2.6e-05	0.000147	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CDKN1B—prostate cancer	2.57e-05	0.000146	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—AKT1—prostate cancer	2.55e-05	0.000144	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—VEGFA—prostate cancer	2.53e-05	0.000143	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CASP3—prostate cancer	2.52e-05	0.000143	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—IL2—prostate cancer	2.52e-05	0.000143	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—STAT3—prostate cancer	2.51e-05	0.000142	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—IL6—prostate cancer	2.51e-05	0.000142	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—KRAS—prostate cancer	2.46e-05	0.000139	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CCND1—prostate cancer	2.46e-05	0.000139	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CTNNB1—prostate cancer	2.43e-05	0.000138	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—MMP9—prostate cancer	2.38e-05	0.000135	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CDKN1A—prostate cancer	2.38e-05	0.000134	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PTEN—prostate cancer	2.37e-05	0.000134	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—MYC—prostate cancer	2.33e-05	0.000132	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—TGFB1—prostate cancer	2.33e-05	0.000132	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—AKT1—prostate cancer	2.31e-05	0.000131	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—EGFR—prostate cancer	2.28e-05	0.000129	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—EP300—prostate cancer	2.26e-05	0.000128	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PIK3CA—prostate cancer	2.26e-05	0.000128	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—SRC—prostate cancer	2.2e-05	0.000124	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—TP53—prostate cancer	2.18e-05	0.000124	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—KRAS—prostate cancer	2.15e-05	0.000122	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—VEGFA—prostate cancer	2.14e-05	0.000121	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—STAT3—prostate cancer	2.12e-05	0.00012	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—IL6—prostate cancer	2e-05	0.000113	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PIK3CA—prostate cancer	1.98e-05	0.000112	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—MYC—prostate cancer	1.97e-05	0.000112	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—TGFB1—prostate cancer	1.97e-05	0.000111	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—EGFR—prostate cancer	1.93e-05	0.000109	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—TP53—prostate cancer	1.91e-05	0.000108	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—AKT1—prostate cancer	1.84e-05	0.000104	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—KRAS—prostate cancer	1.82e-05	0.000103	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—IL6—prostate cancer	1.75e-05	9.92e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PIK3CA—prostate cancer	1.67e-05	9.47e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—TP53—prostate cancer	1.62e-05	9.16e-05	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—AKT1—prostate cancer	1.62e-05	9.15e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—IL6—prostate cancer	1.48e-05	8.38e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—AKT1—prostate cancer	1.37e-05	7.73e-05	CbGpPWpGaD
